PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14973080-0	2004	Pheophorbide a is a specific probe for ABCG2 function and inhibition.	pheophorbide a	0-14	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	39-44	
14973080-1	2004	Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc.	pheophorbide a	0-14	lamin B receptor	Homo sapiens	16-19	
14973080-1	2004	Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc.	pheophorbide a	0-14	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	67-72	
14973080-1	2004	Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc.	pheophorbide a	0-14	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	92-97	
14973080-1	2004	Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc.	chlorophyll catabolite	24-46	lamin B receptor	Homo sapiens	16-19	
14973080-1	2004	Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc.	chlorophyll catabolite	24-46	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	67-72	
14973080-8	2004	We found that 100 micro M of the cyclin-dependent kinase inhibitor UCN-01 or 1 micro M of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport.	7-hydroxystaurosporine	67-70	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	140-145	
14973080-8	2004	We found that 100 micro M of the cyclin-dependent kinase inhibitor UCN-01 or 1 micro M of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport.	7-hydroxystaurosporine	67-70	lamin B receptor	Homo sapiens	155-158	
14973080-8	2004	We found that 100 micro M of the cyclin-dependent kinase inhibitor UCN-01 or 1 micro M of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport.	tariquidar	119-129	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	140-145	
14973080-8	2004	We found that 100 micro M of the cyclin-dependent kinase inhibitor UCN-01 or 1 micro M of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport.	tariquidar	119-129	lamin B receptor	Homo sapiens	155-158	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Irinotecan	59-64	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	30-35	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Irinotecan	59-64	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Irinotecan	59-64	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Topotecan	69-78	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	30-35	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Topotecan	69-78	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	Topotecan	69-78	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	7-hydroxystaurosporine	218-221	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	30-35	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	7-hydroxystaurosporine	218-221	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101	
14973080-9	2004	In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01.	7-hydroxystaurosporine	218-221	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	96-101